Brandywine Global Investment Management’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-45,589
Closed -$2.92M 730
2023
Q3
$2.92M Buy
45,589
+9,313
+26% +$597K 0.03% 484
2023
Q2
$2.24M Buy
36,276
+25
+0.1% +$1.48K 0.02% 531
2023
Q1
$2.11M Sell
36,251
-52
-0.1% -$2.99K 0.02% 541
2022
Q4
$2.16M Sell
36,303
-1,132
-3% -$68.6K 0.02% 542
2022
Q3
$2.37M Sell
37,435
-1,337
-3% -$92.9K 0.02% 503
2022
Q2
$2.71M Buy
38,772
+15,106
+64% +$1.06M 0.02% 478
2022
Q1
$1.66M Buy
23,666
+17,056
+258% +$1.15M 0.01% 565
2021
Q4
$449K Buy
+6,610
New +$457K ﹤0.01% 624

Other funds holding NHC

Brandywine Global Investment Management's NHC Position: Q4 2023 in Review

Brandywine Global Investment Management sold out of National Healthcare (NHC) in Q4 2023, closing a stake of 45,589 shares — an estimated $2.92M sold.

Brandywine Global Investment Management first reported a position in NHC in Q4 2021 and held it in 8 quarters. The position peaked at $2.92M in Q3 2023. 159 funds tracked by Wall St. Rank hold NHC as of Q4 2023.

  • Brandywine Global Investment Management reported no remaining National Healthcare position as of Q4 2023 after selling out during the quarter.
  • Brandywine Global Investment Management sold 45,589 National Healthcare shares in Q4 2023, an estimated $2.92M.
  • Brandywine Global Investment Management first reported a position in National Healthcare in Q4 2021 and held it in 8 quarters.
  • Brandywine Global Investment Management's National Healthcare position peaked at $2.92M in Q3 2023.
  • 159 funds tracked by Wall St. Rank held National Healthcare as of Q4 2023.

Based on Brandywine Global Investment Management's 13F filing for Q4 2023, filed 9 Feb 2024.